Class / Patent application number | Description | Number of patent applications / Date published |
546159000 | Nitrogen, other than as nitro or nitroso, attached directly to the six membered hetero ring by nonionic bonding | 11 |
20090292125 | PROCESS FOR PREPARING TETRAHYDROQUINOLINE DERIVATIVES - The present invention is to provide a process for preparing optically active tetrahydroquinoline derivatives which can be used for the treatment and/or prevention of diseases such as arteriosclerotic diseases, dyslipidemia and the like, and a process for preparing synthetic intermediates thereof. | 11-26-2009 |
20130190500 | PROCESS TO PREPARE 6-CHLORO-3-AMINO-2-(2-HYDROXYPROPYL)-1-AZANAPHTHALENE - This invention relates to a process for the preparation of 6-chloro-3-amino-2-(2-hydroxypropyl)-1-azanapthalene. It comprises treating 6-chloro-3-pyridylium-2-ethoxycarbonyl-1-azanaphthanlene bromide with morpholine at about 80° C., followed by treating the product thereof with methylmagnesium chloride. | 07-25-2013 |
20140371461 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES - The present invention provides a process for effectively producing an N-(hetero)arylazole with high yield, which is useful as a medical or agrochemical product, an organic photoconductor material, an organic electroluminescent element material, or the like. The present invention relates to a process for producing an N-(hetero)arylazole, which includes reacting a (hetero)aryl (pseudo)halide with an NH-azole in the presence of: a catalyst including a palladium compound and a coordination compound; and a basic magnesium compound. | 12-18-2014 |
546160000 | Unsaturated carbocyclic ring bonded directly to the nitrogen | 2 |
20110313166 | MALEATE SALTS OF (E)-N--4-(DIMETHYLAMINO)-2-BUTENAMIDE AND CRYSTALLINE FORMS THEREOF - The present invention relates to maleate salt forms of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide, methods of preparing crystalline maleate salt forms, the associated compounds, and pharmaceutical compositions containing the same. The maleate salts are useful in treating cancers, particularly those affected by kinases of the epidermal growth factor receptor family. | 12-22-2011 |
20140256948 | 3-CYANO-QUINOLINE DERIVATIVES WITH ANTIPROLIFERATIVE ACTIVITY - The present invention concerns the compounds of formula | 09-11-2014 |
546162000 | Nitrogen attached indirectly to the six-membered hetero ring through the directly attached nitrogen by nonionic bonding | 6 |
20100145056 | ACETYL 2-HYDROXY-1,3-DIAMINOALKANES - Disclosed are compounds of the formula: | 06-10-2010 |
20140256949 | QUINOLYL AMINES AS KINASE INHIBITORS - Disclosed are compounds having the formula: | 09-11-2014 |
20150299128 | QUINOLYL HYDRAZONES FOR THE TREATMENT OF TUBERCULOSIS AND RELATED DISEASES - The invention provides quinolyl-hydrazones of Formula I, or pharmaceutically acceptable salts, esters, solvates, isomers and prodrugs thereof as well as pharmaceutical compositions containing these compounds for use in the prophylactic and/or therapeutic treatment of tuberculosis and related diseases, such as, diseases caused by nontuberculous mycobacteria and/or caused by | 10-22-2015 |
20160060249 | QUINOLYL AMINES AS KINASE INHIBITORS - Disclosed are compounds having the formula: | 03-03-2016 |
20190142949 | COVALENT CONJUGATES | 05-16-2019 |
546163000 | Both nitrogens bonded directly to the same acyclic hydrocarbon group | 1 |
20140350262 | Reactivators Of Organophosphorous Inhibited Acetylcholinesterase - The present invention relates to organophosphate-inhibited acetylcholinesterase (AChE) reactivators with central nervous system (CNS) bioavailability and their associated methods of preparation including their use for treatment of exposure to AChE inhibitors such as an organophosphate (OP) insecticides and nerve agents. | 11-27-2014 |